Fintel on MSN

Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30

The average one-year price target for Werewolf Therapeutics (NasdaqGS:HOWL) has been revised to $5.30 / share. This is a ...

'Harry Potter' audiobook: Iwan Rheon and Blake Harrison on finding Lupin's werewolf howl, Pettigrew's mouse voice and almost playing Dobby

They make their debuts as Prof. Remus Lupin (Rheon) and Peter Pettigrew (Harrison) in "Prisoner of Azkaban," released by ...

Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is included on our list of stocks under $1 that will explode. On December 18, 2025, ...
Seeking Alpha

Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space

Werewolf Therapeutics, Inc. develops modified cytokines for cancer treatment, including WTX-124, a modified IL-2, and WTX-330, a modified IL-12. Xilio Therapeutics out-licensed their modified IL-12 to ...
Investing

Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $117k

Director Luke Evnin reported selling shares of Werewolf Therapeutics Inc (NASDAQ:HOWL) between December 2nd and December 4th, 2025. The sales, executed under a prearranged 10b5-1 trading plan, totaled ...
Nasdaq

Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...